Hangzhou Tigermed Consulting Co Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hangzhou Tigermed Consulting Co Ltd with three other
pharmaceutical manufacturers in Asia:
Prodia Widyahusada Tbk PT
sales of 1.47 trillion Indonesian Rupiahs [US$101.89 million]
Falco Holdings Co Ltd
(45.97 billion Japanese Yen [US$405.92 million]
of which 61%
was Medical Test), and
Dr. Lal PathLabs Ltd
based in India
(9.12 billion Indian Rupees [US$129.28 million]
of which 100%
Hangzhou Tigermed Consulting Co Ltd reported sales of 1.69 billion Chinese Renmimbi (US$246.04 million)
December of 2017.
increase of 43.6%
versus 2016, when the company's sales were 1.17 billion Chinese Renmimbi.
Sales at Hangzhou Tigermed Consulting Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 581%).